As of 2024-12-12, the Relative Valuation of Aeglea Bio Therapeutics Inc (AGLE) is (1,344.93) USD. This relative valuation is based on P/E multiples. With the latest stock price at 12.01 USD, the upside of Aeglea Bio Therapeutics Inc based on Relative Valuation is -11298.4%.
The range of the Relative Valuation is (1,315.85) - (1,411.81) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.1x - 24.9x | 18.3x |
| Forward P/E multiples | 12.5x - 19.4x | 18.7x |
| Fair Price | (1,315.85) - (1,411.81) | (1,344.93) |
| Upside | -11056.3% - -11855.3% | -11298.4% |
| Date | P/E |